Yongtai Technology (002326.SZ) subsidiary received a drug registration certificate for ripropyl dicaine cream

Zhitongcaijing · 2d ago

Zhitong Finance App News, Yongtai Technology (002326.SZ) announced that Binhai Meikang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for riprodicaine cream approved and issued by the State Drug Administration.

According to the announcement, riprocaine cream is a combination of lidocaine and pyracaine for topical skin anesthesia in the following conditions: 1. Needle puncture, such as: insertion of a catheter or blood sampling; 2. Superficial surgery, such as: genital mucosa, before superficial surgery or infiltration anesthesia; leg ulcer cleaning/debridement.